Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury

References

• Han, J.Y., Fan, J.Y., Horie, Y., Miura, S., Cui, D.H., Ishii, H., Hibi, T., Tsuneki, H., Kimura, I. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol. Ther. 2008, 117, 280–295.
   PubMed Web of Science ®Google Scholar
• Jiang, H., Meng, F., Li, W., Tong, L., Qiao, H., Sun, X. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 2007, 141, 32–40.
   PubMed Web of Science ®Google Scholar
• Shin, T., Kuboki, S., Huber, N., Eismann, T., Galloway, E., Schuster, R., Blanchard, J., Pritts, T.A., Lentsch, A.B. Activation of peroxisome proliferator-activated receptor-gamma during hepatic ischemia is age-dependent. J. Surg. Res. 2008, 147, 200–205.
   PubMed Web of Science ®Google Scholar
• van Gulik, T.M., de Graaf, W., Dinant, S., Busch, O.R., Gouma, D.J. Vascular occlusion techniques during liver resection. Dig. Surg. 2007, 24, 274–281.
   PubMedGoogle Scholar
• He, X.S., Ma, Y., Wu, L.W., Wu, J.L., Hu, R.D., Chen, G.H., Huang, J.F. Dynamical changing patterns of glycogen and enzyme histochemical activities in rat liver graft undergoing warm ischemia injury. World J. Gastroenterol. 2005, 11, 2662–2665.
   PubMed Web of Science ®Google Scholar
• Lentsch, A.B., Kato, A., Yoshidome, H., McMasters, K.M., Edwards, M.J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000, 32, 169–173.
   PubMed Web of Science ®Google Scholar
• Liu, T.Z., Lee, K.T., Chern, C.L., Cheng, J.T., Stern, A., Tsai, L.Y. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann. Clin. Lab. Sci. 2001, 31, 383–390.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H. Reactive oxygen and mechanisms of inflammatory liver injury. J. Gastroenterol. Hepatol. 2000, 15, 718–724.
   PubMed Web of Science ®Google Scholar
• Weiss, S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 1989, 320, 365–376.
   PubMed Web of Science ®Google Scholar
• Shao, H., Shen, Y., Liu, H., Dong, G., Qiang, J., Jing, H. Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model. Ann. Thorac. Surg. 2007, 84, 2011–2018.
   PubMed Web of Science ®Google Scholar
• Manzoni, M., Rollini, M. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol. 2002, 58, 555–564.
   PubMed Web of Science ®Google Scholar
• Kwak, B., Mulhaupt, F., Myit, S., Mach, F. Statins as a newly recognized type of immunomodulator. Nat. Med. 2000, 6, 1399–1402.
   PubMed Web of Science ®Google Scholar
• Case, C.C., Ballantyne, C.M. Statins and inflammatory markers. Curr. Atheroscler. Rep. 2002, 4, 42–47.
   PubMedGoogle Scholar
• Ikeda, Y., Young, L.H., Lefer, A.M. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats. J. Cardiovasc. Pharmacol. 2003, 41, 649–656.
   PubMed Web of Science ®Google Scholar
• Bulhak, A., Sjoquist, P., Pernow, J. Rosuvastatin protects the myocardium against ischaemia-reperfusion injury via inhibition of GGPP synthesis. Cardiovasc. J. S. Afr. 2004, 15, S11.
   Google Scholar
• Weinberg, E.O., Scherrer-Crosbie, M., Picard, M.H., Nasseri, B.A., MacGillivray, C., Gannon, J., Lian, Q., Bloch, K.D., Lee, R.T. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H1802–H1809.
   Google Scholar
• Bulhak, A.A., Gourine, A.V., Gonon, A.T., Sjöquist, P.O., Valen, G., Pernow, J. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level. Acta Physiol. Scand. 2005, 183, 151–159.
   PubMedGoogle Scholar
• Di Napoli, P., Taccardi, A.A., Grilli, A., De Lutiis, M.A., Barsotti, A., Felaco, M., De Caterina, R. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovasc. Res. 2005, 66, 462–471.
   PubMed Web of Science ®Google Scholar
• Dibazar, F., Hajipour, B., Hosseinian, M.M., Hemmati, M.R., Ghandiha, A. Simvastatin decreases hepatic ischaemia/reperfusion-induced liver and lung injury in rats. Folia Morphol. (Warsz) 2008, 67, 231–235.
   PubMedGoogle Scholar
• Bouali, S., Evrard, A., Chastanet, M., Lesch, K.P., Hamon, M., Adrien, J. Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur. J. Neurosci. 2003, 18, 2203–2212.
   PubMedGoogle Scholar
• Lukivskaya, O., Knas, M., Dudzik, D., Borzym-Kluczyk, M., Lis, R., Buko, V., Zwierz, K. Effects of statins on liver fibrosis reversibility and activities of lysosomal exoglycosidases E&C. Hepatology 2007, 3, 14–17.
   Google Scholar
• Jaeschke, H., Farhood, A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 1991, 260, G355–G362.
   PubMed Web of Science ®Google Scholar
• McGown, C.C., Brookes, Z.L. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br. J. Anaesth. 2007, 98, 163–175.
   PubMed Web of Science ®Google Scholar
• Locksley, R.M., Killeen, N., Lenardo, M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104, 487–501.
   PubMed Web of Science ®Google Scholar
• Ishihara, K., Hirano, T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2003, 13, 357–368.
   Google Scholar
• Chello, M., Patti, G., Candura, D., Mastrobuoni, S., Di Sciascio, G., Agrò, F., Carassiti, M., Covino, E. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit. Care Med. 2006, 34, 660–667.
   PubMed Web of Science ®Google Scholar
• Souza Neto, J.L., Araújo Filho, I., Rego, A.C., Dominici, V.A., Azevedo, I.M., Egito, E.S., Brandão-Neto, J., Medeiros, A.C. Effects of simvastatin in abdominal sepsis in rats. Acta Cir. Bras. 2006, 21(Suppl. 4), 8–12.
   PubMedGoogle Scholar
• Almeida, J.L., Sampietre, S.N., Mendonça Coelho, A.M., Trindade Molan, N.A., Machado, M.C., Monteiro da Cunha, J.E., Jukemura, J. Statin pretreatment in experimental acute pancreatitis. JOP 2008, 9, 431–439.
   PubMedGoogle Scholar
• Li, W., Asagami, T., Matsushita, H., Lee, K.H., Tsao, P.S. Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice. J. Pharmacol. Exp. Ther. 2005, 313, 557–562.
   PubMed Web of Science ®Google Scholar
• Weber, C., Schober, A., Zernecke, A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1997–2008.
   PubMed Web of Science ®Google Scholar
• Sironi, L., Gianazza, E., Gelosa, P., Guerrini, U., Nobili, E., Gianella, A., Cremonesi, B., Paoletti, R., Tremoli, E. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 598–603.
   PubMed Web of Science ®Google Scholar
• de Mendonça-Filho, H.T., Pereira, K.C., Fontes, M., Vieira, D.A., de Mendonça, M.L., Campos, L.A., Castro-Faria-Neto, H.C. Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study. Crit. Care 2006, 10, R46.
   PubMed Web of Science ®Google Scholar
• Eskdale, J., Kube, D., Tesch, H., Gallagher, G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997, 46, 120–128.
   PubMed Web of Science ®Google Scholar
• Wang, Q., Fang, C.H., Hasselgren, P.O. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281, R1013–R1023.
   PubMed Web of Science ®Google Scholar
• Grimbaldeston, M.A., Nakae, S., Kalesnikoff, J., Tsai, M., Galli, S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 2007, 8, 1095–1104.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Cheng, X., Liao, Y., Lu, B., Yang, B., Ge, H., Wang, M., Liu, Y., Guo, Z., Zhang, L. Simvastatin regulates myocardial cytokine expression and improves ventricular remodeling in rats after acute myocardial infarction. Cardiovasc. Drugs Ther. 2005, 19, 13–21.
   PubMedGoogle Scholar
• Karupiah, C. Cytokines and chemokines in infectious diseases handbook [Book Reviews]. Immunol. Cell Biol. 2003, 81, 496–498.
   Google Scholar
• Palinski, W., Tsimikas, S. Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis. J. Am. Soc. Nephrol. 2002, 13, 1673–1681.
   PubMed Web of Science ®Google Scholar
• Van Laethem, J.L., Eskinazi, R., Louis, H., Rickaert, F., Robberecht, P., Devière, J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998, 43, 408–413.
   PubMed Web of Science ®Google Scholar
• Steffens, S., Mach, F. Drug insight: immunomodulatory effects of statins—potential benefits for renal patients? Nat. Clin. Pract. Nephrol. 2006, 2, 378–387.
   PubMedGoogle Scholar